'Lourie' diaporamas de présentation

Indirect Infringement II

544 views • 51 slides

412 views • 19 slides

What is Happening to Patent Eligibility and What Can We Do About It?

What is Happening to Patent Eligibility and What Can We Do About It?. June 24, 2014 Bruce D. Sunstein Denise M. Kettelberger, Ph.D. Sunstein Kann Murphy & Timbers LLP. The Phenomenon.

267 views • 16 slides

Brian V. Slater ACI 12 th Annual Maximizing Pharmaceutical Patent Life Cycles

The Combined Impact of Prior Art Obviousness and Obviousness-Type Double Patenting on Pharmaceutical Patent Life Cycle Strategies. Brian V. Slater ACI 12 th Annual Maximizing Pharmaceutical Patent Life Cycles New York, October 4-5, 2011. 5. 4. 3. Opinions. 2. 1. 0. NCE. Stereoisomers.

305 views • 16 slides